Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Amortization of Deferred Charges (2023)

Historic Amortization of Deferred Charges for iBio (IBIO) over the last 1 years, with Q4 2023 value amounting to $30000.0.

  • iBio's Amortization of Deferred Charges changed N/A to $30000.0 in Q4 2023 from the same period last year, while for Jun 2024 it was $120000.0, marking a year-over-year change of. This contributed to the annual value of $120000.0 for FY2024, which is 5041.32% down from last year.
  • Per iBio's latest filing, its Amortization of Deferred Charges stood at $30000.0 for Q4 2023.
  • In the past 5 years, iBio's Amortization of Deferred Charges registered a high of $90000.0 during Q3 2023, and its lowest value of $30000.0 during Q4 2023.